Literature DB >> 19809778

Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.

Serena Vettori1, Stefania Staibano, Massimo Mascolo, Gennaro Ilardi, Gabriele Valentini.   

Abstract

The occurrence of non-Hodgkin's lymphoma in systemic sclerosis is an uncommon event. In our scleroderma cohort, a case of primary gastric B-cell lymphoma was diagnosed in 2007. The patient was a 45-year-old woman suffering from late systemic sclerosis sine scleroderma in whom non-Hodgkin's lymphoma presented with progressive weight loss, later with gastrointestinal symptoms. Subsequently, we retrospectively analyzed the charts of 251 systemic sclerosis patients consecutively admitted to our Unit from 2000 to 2008 to search for other non-Hodgkin's lymphoma cases (prevalence, 0.49%). Then we performed a Pubmed search for "systemic sclerosis & non-Hodgkin's lymphoma," limited to the English language. Twenty detailed cases of such an association were found, pointing out the following: non-Hodgkin's lymphoma seems to be associated to old age, female sex, diffuse cutaneous subset and early disease; B-cell lymphoma subtypes are the majority; the interval between systemic sclerosis and lymphoma onset is usually short; systemic sclerosis could present as a paraneoplastic syndrome in some cases. We concluded that, although rare, the association of systemic sclerosis and non-Hodgkin's lymphoma may not be coincidental and the clinician should be aware of the risk for lymphoproliferative disorders in scleroderma patients. This is the first description of non-Hodgkin's lymphoma in systemic sclerosis sine scleroderma. The insidious onset of gastric lymphomas, mimicking the most common features of gastrointestinal involvement in systemic sclerosis is underlined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809778     DOI: 10.1007/s10067-009-1286-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  43 in total

1.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

2.  Scleroderma, pleural calcification and reticulum cell sarcoma of the lungs.

Authors:  R Romey; M Moskowitz
Journal:  Chest       Date:  1973-09       Impact factor: 9.410

3.  Progressive systemic sclerosis complicated with primary cerebral malignant lymphoma.

Authors:  A Suzuki; H Ohoike; Y Kitagawa; Y Matsuoka; S Irimajiri
Journal:  Intern Med       Date:  1994-09       Impact factor: 1.271

4.  Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.

Authors:  László Váróczy; Lajos Gergely; Margit Zeher; Gyula Szegedi; Arpád Illés
Journal:  Rheumatol Int       Date:  2002-08-29       Impact factor: 2.631

5.  Angioimmunoblastic T cell lymphoma with an unusual proliferation of Epstein-Barr virus-associated large B cells arising in a patient with progressive systemic sclerosis.

Authors:  Hidesuke Yamamoto; Hiroshi Miwa; Yoshiro Kato; Shigeo Nakamura; Kazuo Hara; Masakazu Nitta
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis.

Authors:  L Baldini; A Guffanti; A Ferrari; D Castagnone; B Mascagni; N Fracchiolla; M Colombi; A T Maiolo
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

8.  Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Authors:  Gili G Halfteck; Moran Elboim; Chamutal Gur; Hagit Achdout; Hormas Ghadially; Ofer Mandelboim
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.

Authors:  Lene Mellemkjaer; Ruth M Pfeiffer; Eric A Engels; Gloria Gridley; William Wheeler; Kari Hemminki; Jørgen H Olsen; Lene Dreyer; Martha S Linet; Lynn R Goldin; Ola Landgren
Journal:  Arthritis Rheum       Date:  2008-03

10.  Mucosa-associated lymphoid tissue lymphoma (MALT) of salivary glands and scleroderma: a case report.

Authors:  Monika Prochorec-Sobieszek; Paweł Mielnik; Teresa Wagner; Hanna Chwalińska-Sadowska
Journal:  Clin Rheumatol       Date:  2004-05-19       Impact factor: 2.980

View more
  4 in total

Review 1.  Systemic Sclerosis Association with Malignancy.

Authors:  Gemma Lepri; Martina Catalano; Silvia Bellando-Randone; Serena Pillozzi; Elisa Giommoni; Roberta Giorgione; Cristina Botteri; Marco Matucci-Cerinic; Lorenzo Antonuzzo; Serena Guiducci
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

2.  Primary CNS lymphoma in scleroderma: a case series.

Authors:  Danielle M Robinett; Laura K Hummers; Meaghan Morris; Amy S Duffield; Ami A Shah
Journal:  J Scleroderma Relat Disord       Date:  2020-11-11

3.  Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.

Authors:  M Colaci; D Giuggioli; C Vacchi; C Ferri
Journal:  Case Rep Rheumatol       Date:  2017-05-04

Review 4.  Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.

Authors:  Alexandre Thibault Jacques Maria; Léo Partouche; Radjiv Goulabchand; Sophie Rivière; Pauline Rozier; Céline Bourgier; Alain Le Quellec; Jacques Morel; Danièle Noël; Philippe Guilpain
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.